Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0011849 (
diabetes
)
277,896
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Sialic acid acetylesterase
(
SIAE
) is an enzyme that negatively regulates B lymphocyte antigen receptor signalling and is required for the maintenance of immunological tolerance in mice. Heterozygous loss-of-function germline rare variants and a homozygous defective polymorphic variant of
SIAE
were identified in 24/923 subjects of European origin with relatively common autoimmune disorders and in 2/648 controls of European origin. All heterozygous loss-of-function
SIAE
mutations tested were capable of functioning in a dominant negative manner. A homozygous secretion-defective polymorphic variant of
SIAE
was catalytically active, lacked the ability to function in a dominant negative manner, and was seen in eight autoimmune subjects but in no control subjects. The odds ratio for inheriting defective
SIAE
alleles was 8.6 in all autoimmune subjects, 8.3 in subjects with rheumatoid arthritis, and 7.9 in subjects with type I
diabetes
. Functionally defective
SIAE
rare and polymorphic variants represent a strong genetic link to susceptibility in relatively common human autoimmune disorders.
...
PMID:Functionally defective germline variants of sialic acid acetylesterase in autoimmunity. 2055 25